Linke, Axel <br/><br/>
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.  [electronic resource] 

 -  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions  Nov 2017 
 - 1016-1026 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1522-726X 
<br/><br/><label>Standard No.: </label>10.1002/ccd.27154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Antithrombins--administration & dosage<br/>Aortic Valve--diagnostic imaging<br/>Aortic Valve Stenosis--complications<br/>Cause of Death--trends<br/>Dose-Response Relationship, Drug<br/>Europe--epidemiology<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Follow-Up Studies<br/>Heart Valve Prosthesis<br/>Heparin--administration & dosage<br/>Hirudins--administration & dosage<br/>Humans<br/>Incidence<br/>Infusions, Intravenous<br/>Male<br/>Peptide Fragments--administration & dosage<br/>Practice Guidelines as Topic<br/>Prosthesis Design<br/>Recombinant Proteins--administration & dosage<br/>Retrospective Studies<br/>Survival Rate--trends<br/>Thrombolytic Therapy--methods<br/>Thrombosis--epidemiology<br/>Time Factors<br/>Transcatheter Aortic Valve Replacement--standards<br/>Treatment Outcome<br/>United States--epidemiology